BIM23B065: Clinical Trials

1 trial of BIM23B065, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow BIM23B065: new trials by email Literature Review of BIM23B065 trials Research Report on BIM23B065

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly
BIM23B065 - Acromegaly
Phase 2TerminatedIpsen42017-01-262019-03-08

Conditions studied

Acromegaly (1)

Sponsors

Ipsen (1)

Countries

Belgium (1)  ·  Hungary (1)  ·  Serbia (1)  ·  Ukraine (1)

NIH funding

2015 (1)